28 products were found matching "K19261"!

1 from 3 pages
No results were found for the filter!
Sisunatovir
Sisunatovir

Item number: Cay42124-10

An RSV fusion inhibitor (IC50 = 0.9 nM), reduces RSV A2 replication in a plaque reduction assay in vitro (EC50 = 1.3 nM), decreases lung viral titers in a mouse model of RSV infection at 1, 10, or 50 mg/kg. Formulation: A solid. InChI:...
Keywords: RV521,...
Application: RSV fusion inhibitor
CAS 1903763-82-5
MW: 446.44 D
From 163.00€ *
Review
respiratory syncytial virus B Fusion glycoprotein F0 (F), partial, human, recombinant
respiratory syncytial virus B Fusion glycoprotein F0 (F),...

Item number: CSB-YP516611HXK.1

Organism: Human respiratory syncytial virus B (strain B1). Source: Yeast. Expression Region: 137-574aa. Protein Length: Partial. Tag Info: N-terminal 6xHis-tagged. Target Protein Sequence: FLGFLLGVGS AIASGIAVSK VLHLEGEVNK IKNALLSTNK AVVSLSNGVS VLTSKVLDLK NYINNQLLPI VNQQSCRISN IETVIEFQQK NSRLLEINRE FSVNAGVTTP...
Keywords: F, Recombinant Human respiRatory syncytial virus B Fusion glycoprotein F0 (F), partial
Application: Activity not tested
Expressed in: Yeast
Origin: Human respiratory syncytial virus B
MW: 50.1 kD
From 242.00€ *
Review
Sisunatovir
Sisunatovir

Item number: TGM-T24747-2mg

Description: RV521 is a highly effective fusion inhibitor. It designed to treat RSV disease by the target of a surface protein that mediates RSV binding to cellular receptors. Target: Others. Smiles: NCc1ccc2n(CCCC(F)(F)F)c(CN3C(=O)C4(CC4)c4ccc(F)cc34)nc2c1
Keywords: RV521, RV-521, RV 521, RV521 free base
Application: Targets Pneumoviridae fusion glycoprotein F0 (F)
CAS 1903763-82-5
MW: 446.44 D
From 83.00€ *
Review
Clesrovimab
Clesrovimab

Item number: TGM-T77132-10mg

Description: Clesrovimab (MK1654) is an anti-respiratory syncytial virus protein F human monoclonal antibody for the prevention and treatment of respiratory syncytial virus infections. Target: Others. References: Qiu X, et al. Development of mRNA vaccines against respiratory syncytial virus (RSV). Cytokine Growth...
Keywords: MK-1654
Application: Targets Pneumoviridae fusion glycoprotein F0 (F)
CAS 2429913-18-6
From 430.00€ *
Review
Palivizumab
Palivizumab

Item number: TGM-T76907-100mg

Description: Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV). Target: RSV. References: Palivizumab, a humanized respiratory syncytial...
Keywords: MEDI 493, Synagis
Application: Targets Pneumoviridae fusion glycoprotein F0 (F)
CAS 188039-54-5
From 215.00€ *
Review
Sisunatovir hydrochloride
Sisunatovir hydrochloride

Item number: TGM-T9197-100mg

Description: Sisunatovir hydrochloride (RV521 HCl) is an orally available inhibitor of the RSV-F protein that has exhibited potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses in vitro (IC50 = 1.4 nM for RSV-A, IC50 = 1.0 nM for RSV-B). Target: RSV. Smiles:...
Keywords: Sisunatovir HCl, RV521 HCl
Application: Targets Pneumoviridae fusion glycoprotein F0 (F)
CAS 1903763-83-6
MW: 482.9 D
From 49.00€ *
Review
Presatovir
Presatovir

Item number: TGM-TQ0085-100mg

Description: Presatovir (GS-5806) (GS-5806) is a novel, orally bioavailable RSV fusion inhibitor (mean EC50: 0.43 nM). Target: RSV. Smiles: Cc1cn2nc(cc2nc1N1CC[C@H](N)C1)[C@@H]1CCCCN1C(=O)c1cc(Cl)ccc1NS(C)(=O)=O. References: Samuel D, et al. GS-5806 inhibits pre- to postfusion conformational changes of the...
Keywords: GS-5806
Application: Targets Pneumoviridae fusion glycoprotein F0 (F)
CAS 1353625-73-6
MW: 532.06 D
From 55.00€ *
Review
Nirsevimab (YTE Mutant)
Nirsevimab (YTE Mutant)

Item number: BPS-83759-1

Nirsevimab, also known as MEDI8897, is a recombinant neutralizing monoclonal antibody developed against human respiratory syncytial virus (RSV). It is an IgG1kappa antibody, that has a triple mutation in the Fc region designed to increase its serum half-life. The YTE (M252Y/S254T/T256E) mutation increases the...
Keywords: F, Fusion glycoprotein F0
Application: Biochemical, cellular assays
Host: Hamster
Species reactivity: human
CAS 1989556-22-0
From 1,500.00€ *
Review
Anti-RSV F (11A9), Epitope II, biotinylated
Anti-RSV F (11A9), Epitope II, biotinylated

Item number: NOV-DA091BDL.100ug

Respiratory syncytial virus (RSV) is a highly contagious pathogen of the respiratory tract, primarily in infants and the elderly. A vaccine against RSV is currently not available, but is desired due to the high disease burden.RSV has two major surface glycoproteins (G and F) that play important roles in the initial...
Keywords: Anti-F, Biotinylated RSV F Antibody (11A9), Epitope II
Host: Human
Species reactivity: Biotinylated RSV F Antibody (11A9), Epitope II
From 450.00€ *
Review
Anti-RSV Pre-F (3C12), Epitope Phi
Anti-RSV Pre-F (3C12), Epitope Phi

Item number: NOV-DA101.100ug

Respiratory syncytial virus (RSV) is a highly contagious pathogen of the respiratory tract, primarily in infants and the elderly. A vaccine against RSV is currently not available, but is desired due to the high disease burden.RSV has two major surface glycoproteins (G and F) that play important roles in the initial...
Keywords: Anti-F, RSV Pre-F Antibody (3C12), Epitope Phi
Host: Human
Species reactivity: RSV Pre-F Antibody (3C12), Epitope Phi
From 250.00€ *
Review
Anti-RSV F (4D5), Epitope I, biotinylated
Anti-RSV F (4D5), Epitope I, biotinylated

Item number: NOV-DA102BDL.100ug

Respiratory syncytial virus (RSV) is a highly contagious pathogen of the respiratory tract, primarily in infants and the elderly. A vaccine against RSV is currently not available, but is desired due to the high disease burden.RSV has two major surface glycoproteins (G and F) that play important roles in the initial...
Keywords: Anti-F, Biotinylated RSV F Antibody (4D5), Epitope I
Host: Human
Species reactivity: Biotinylated RSV F Antibody (4D5), Epitope I
From 495.00€ *
Review
Anti-RSV F (4B9), Epitope III
Anti-RSV F (4B9), Epitope III

Item number: NOV-DA110.100ug

Respiratory syncytial virus (RSV) is a highly contagious pathogen of the respiratory tract, primarily in infants and the elderly. A vaccine against RSV is currently not available, but is desired due to the high disease burden.RSV has two major surface glycoproteins (G and F) that play important roles in the initial...
Keywords: Anti-F, RSV F Antibody (4B9), Epitope III
Host: Human
Species reactivity: RSV F Antibody (4B9), Epitope III
From 328.00€ *
Review
1 from 3 pages